A. Charles Morgan
Impact in
-
- Radiopharmaceutical Chemistry and Applications
- Monoclonal and Polyclonal Antibodies Research
- Immunology top 5%
- Toxin Mechanisms and Immunotoxins
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
Papers in
-
- Monoclonal and Polyclonal Antibodies Research 15
- Radiopharmaceutical Chemistry and Applications 10
- Immunology 15
- Toxin Mechanisms and Immunotoxins 9
- Immune Cell Function and Interaction 4
- Co-authors
- Robert W. Schroff (13 shared papers)Kenneth A. Foon (14 shared papers)Beppino C. Giovanella (3 shared papers)John S. Stehlin (2 shared papers)Robert K. Oldham (3 shared papers)C S Woodhouse (18 shared papers)Paul G. Abrams (14 shared papers)Renata Reisfeld (3 shared papers)
- Journals
- The Journal of Immunology (5 papers)Molecular Immunology (4 papers)JNCI Journal of the National Cancer Institute (4 papers)Bioconjugate Chemistry (4 papers)Journal of Immunological Methods (4 papers)
- Partner nations
- United StatesCanadaNorway
In The Last Decade
A. Charles Morgan
66 papers receiving 2.3k citations
A. Charles Morgan's Hit Papers
Peers
Comparison fields: 5 of 64
- Radiology, Nuclear Medicine and Imaging 1.1k
- Immunology 318
- Oncology 119
- Rheumatology 75
- Biomedical Engineering 108
Countries citing papers authored by A. Charles Morgan
This map shows the geographic impact of A. Charles Morgan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Charles Morgan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Charles Morgan more than expected).
Fields of papers citing papers by A. Charles Morgan
This network shows the impact of papers produced by A. Charles Morgan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Charles Morgan. The network helps show where A. Charles Morgan may publish in the future.
Co-authors
The 25 scholars most cited alongside A. Charles Morgan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 69 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Human anti-murine immunoglobulin responses in patients receiving monoclonal antibody therapy. Hit paper breakdown → | 1985 | 428 |
| 2 | Selective lethal effect of supranormal temperatures on human neoplastic cells. | 1976 | 171 |
| 3 | 1984 | 169 | |
| 4 | 1981 | 165 | |
| 5 | Development of a stable radioiodinating reagent to label monoclonal antibodies for radiotherapy of cancer. | 1989 | 156 |
| 6 | 1988 | 147 | |
| 7 | Selective lethal effect of supranormal temperatures on mouse sarcoma cells. | 1973 | 130 |
| 8 | 1987 | 103 | |
| 9 | 1991 | 69 | |
| 10 | Successful imaging of malignant melanoma with technetium-99m-labeled monoclonal antibodies. | 1989 | 68 |
| 11 | Kinetic model for the biodistribution of an 111In-labeled monoclonal antibody in humans. | 1987 | 64 |
| 12 | 1984 | 63 | |
| 13 | 1996 | 62 | |
| 14 | 1989 | 61 | |
| 15 | Effect of antibody dose on the imaging and biodistribution of indium-111 9.2.27 anti-melanoma monoclonal antibody. | 1988 | 57 |
| 16 | Immunotoxins to a human melanoma-associated antigen: comparison of gelonin with ricin and other A chain conjugates. | 1987 | 55 |
| 17 | Biodistribution, pharmacokinetic, and imaging studies with 186Re-labeled NR-LU-10 whole antibody in LS174T colonic tumor-bearing mice. | 1990 | 44 |
| 18 | 1979 | 38 | |
| 19 | Detection of immune complex-like materials in cancer patients' sera: a comparative study of results obtained with the C1q deviation and C1q binding tests. | 1978 | 34 |
| 20 | 1997 | 31 |
About A. Charles Morgan
A. Charles Morgan is a scholar working on Radiology, Nuclear Medicine and Imaging, Immunology, Rheumatology, Cell Biology and Cancer Research, having authored 69 papers that have together received 2.7k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (15 papers), Radiopharmaceutical Chemistry and Applications (10 papers), Toxin Mechanisms and Immunotoxins (9 papers), Immune Cell Function and Interaction (4 papers), Folate and B Vitamins Research (2 papers), Proteoglycans and glycosaminoglycans research (1 paper), Protease and Inhibitor Mechanisms (1 paper) and Ultrasound and Hyperthermia Applications (1 paper). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (1.1k citations), Immunology (318 citations), Oncology (119 citations), Rheumatology (75 citations) and Biomedical Engineering (108 citations). A. Charles Morgan has collaborated with scholars based in United States, Canada and Norway. Frequent co-authors include Robert W. Schroff, Kenneth A. Foon, Beppino C. Giovanella, John S. Stehlin, Robert K. Oldham, C S Woodhouse, Paul G. Abrams, Renata Reisfeld, Darrell R. Galloway and Alan R. Fritzberg. Their work appears in journals such as The Journal of Immunology, Molecular Immunology, JNCI Journal of the National Cancer Institute, Bioconjugate Chemistry and Journal of Immunological Methods.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.